Treatment of prostate and renal cancer with oral drugs (abiratarone and antiangiogenic agents): Positioning statement from the Spanish Association of Urology

  1. Villavicencio, H.
  2. Hernández, C.
  3. Gómez, A.
  4. Cózar, J.M.
  5. Rodríguez-Antolín, A.
  6. Prieto, L.
  7. De Cabo, M.
  8. Malet, J.M.
  9. Extramiana, J.
  10. Mata, J.
  11. Arrabal, M.
  12. Server, G.
  13. Solsona, E.
  14. Del Valle, J.I.
  15. Miguélez, E.
  16. Gutiérrez, E.
  17. Elizalde, A.
  18. Mateos, J.
  19. Artiles, J.L.
  20. Jiménez-Cidre, M.
  21. Nalda, L.M.
  22. Cruz, N.
  23. Ozonas, M.
  24. Caffaratti, J.
  25. Esteban, M.
  26. Unda, M.
  27. Reina, C.
  28. Álvarez-Ossorio, J.L.
  29. Lledó, E.
  30. Angulo, J.C.
  31. Show all authors +
Journal:
Actas Urologicas Espanolas

ISSN: 0210-4806

Year of publication: 2013

Volume: 37

Issue: 6

Pages: 321-323

Type: Editorial

DOI: 10.1016/J.ACURO.2013.04.001 GOOGLE SCHOLAR

Sustainable development goals